Risk factors for intraocular melanoma and occupational exposure

British Journal of Ophthalmology

Volumn 83, Issue 10, 1999, Pages 1190-1193

  Lutz, Jean Michel ^a   Cree, Ian A ^b   Foss, Alex J ^c  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER LOCALIZATION; CANCER STATISTICS; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHOROID MELANOMA; GENETIC PREDISPOSITION; HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK FACTOR; SHORT SURVEY; ULTRAVIOLET RADIATION; UVEA MELANOMA;

EID: 0032834736     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.10.1190     Document Type: Short Survey

References (91)

1. Swerdlow AJ. Epidemiology of eye cancer in adults in England and Wales, 1962-1977. Am J Epidemiol 1983;118:294-300.
2. Keller AZ. Histology, survivorship and related factors in the epidemiology of eye cancers. Am J Epidemiol 1973;97:386-93.
3. Strickland D, Lee JA. Melanomas of eye: stability of rates. Am J Epidemiol 1981;113:700-2.
4. Osterlind A. Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer 1987;40;161-4.
5. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
6. Mahoney MC, Burnett WS, Majerovics A, et al. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology 1990;97:1143-7.
7. Foss AJ, Dolin PJ. Trends in eye cancer mortality among adults in the USA and England and Wales. Br J Cancer 1996;74:1687-9.
8. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol (Suppl) 1977:1-64.
9. Sahel JA, Earle JD, Albert DM. Intraocular melanomas. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993:1662-78.
10. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991;98:383-91.
11. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the MD Anderson Cancer Center experience and prognostic factors. Cancer 1995;76:1665-70.
12. Leyvraz S, Spataro V, Bauer J, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997;15:2589-95.
13. Neale MH, Myatt N, Cree IA, et al. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br J Cancer 1999;79:1487-93.
14. Zimmerman LE. Problems in the diagnosis of malignant melanomas of the choroid and ciliary body. The 1972 Arthur J Bedell Lecture. Am J Ophthalmol 1973;75:917-29.
15. Shields JA. Modern methods in the diagnosis of uveal melanomas. Trans Ophthalmol Soc UK 1977;97:407-11.
16. Gamel JW, McLean IW. Quantitative analysis of the Callender classification of uveal melanoma cells. Arch Ophthalmol 1977;95:686-91.
17. Foss AJ, Alexander RA, Jefferies LW, et al. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996;56:2900-3.
18. Gamel JW, McLean IW, Foster WD, et al. Uveal melanomas: correlation of cytologic features with prognosis. Cancer 1978;41:1897-901.
19. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol 1978;62:420-5.
20. Gundersen T, Smith TR, Zakov N, et al. Choroidal melanocytic tumor observed for 41 years before enucleation. Arch Ophthalmol 1978;96:2089-92.
21. Velazquez N, Jones IS. Ocular and oculodermal melanocytosis associated with uveal melanoma. Ophthalmology 1983;90:1472-6.
22. Gonder JR, Shields JA, Albert DM, et al. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology 1982;89:953-60.
23. Rootman J, Galiagher RR. Color as a risk factor in iris melanoma. Am J Ophthalmol 1984;98:558-61.
24. Galiagher RP, Elwood JM, Rootman J, et al. Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1985;74:775-8.
25. Tucker MA, Shields JA, Hartge P, et al. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985;313:789-92.
26. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985;45:1855-61.
27. Hartge P, Tucker MA, Shields JA, et al. Case-control study of female hormones and eye melanoma. Cancer Res 1989;49:4622-5.
28. Lischko AM, Seddon JM, Gragoudas ES, et al. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study [see comments]. Ophthalmology 1989;96:1716-21.
29. Holly EA, Aston DA, Ahn DK, et al. Uveal melanoma, hormonal and reproductive factors in women. Cancer Res 1991;51:1370-2.
30. Albert DM. The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II. Am J Ophthalmol 1997;123:729-41.
31. COMS. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no 9 [see comments]. Am J Ophthalmol 1998;125:767-78.
32. COMS. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no 6 [see comments]. Am J Ophthalmol 1998;125:745-66.
33. Greer CH. Congenital melanoma of the anterior uvea. Arch Ophthalmol 1966;76:77-8.
34. Lynch HT, Anderson DE, Krush AJ. Heredity and intraocular malignant melanoma. Study of two families and review of forty-five cases. Cancer 1968;21:11-25
35. Lynch HT, Krush AJ. Heredity and malignant melanoma:implications for early cancer detection. Can Med Assoc J 1968;99:17-21.
36. Green GJ, Hong WK, Everett JR, et al. Familial intraocular malignant melanoma: a case report. Cancer 1978;41:2481-3.
37. Walker JP, Weiter JJ, Albert DM, et al. Uveal malignant melanoma in three generations of the same family. Am J Ophthalmol 1979;88:723-6.
38. Greene MH, Sanders RJ, Chu FC, et al. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol 1983;96:238-45.
39. Simons KB, Hale LM, Morrison HM Jr, et al. Choroidal malignant melanoma in siblings. Am J Ophthalmol 1983;96:675-80.
40. Canning CR, Hungerford J. Familial uveal melanoma. Br J Ophthalmol 1988;72:241-3.
41. Broadway D, Lang S, Harper J, et al. Congenital malignant melanoma of the eye. Cancer 1991;67:2642-52.
42. Young LH, Egan KM, Walsh SM, et al. Familial uveal melanoma. Am J Ophthalmol 1994;117:516-20.
43. Bercher L, Munier F, Zografos L, et al. Familial uveal melanoma. Klin Monatsbl Augenheilkd 1995;206:384-7.
44. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. II. Relationship of uveal nevi to malignant melanomas. Cancer 1967;20:493-507.
45. Ganley JP, Comstock GW. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol 1973;76:1-25
46. Vink J, Crijns MB, Mooy CM, et al. Ocular melanoma in families with dysplastic nevus syndrome. J Am Acad Dermatol 1990;23:858-62,
47. Van Hees CL, de Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case- control study. J Invest Dermatol 1994;103:202-5.
48. Bataille V, Sasieni P, Cuzick J, et al. Risk of ocular melanoma in relation to cutaneous and iris naevi. Int J Cancer 1995;60:622-6.
49. Lee JA, Storer BE. Malignant melanoma female/male death ratios letter. Lancet 1981;1:14.
50. Reintgen DS, McCarty KS Jr, Vollmer R, et al. Malignant melanoma and pregnancy. Cancer 1985;55:1340-4.
51. Egan KM, Walsh SM, Seddon JM, et al. An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology 1993;100:1160-5.
52. Cooke KR, Skegg DC, Fraser J. Socio-economic status, indoor and outdoor work, and malignant melanoma. Int J Cancer 1984;34:57-62.
53. Graham S, Marshall J, Haughey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985;122:606.
54. Tucker MA, Hartge P, Shields JA. Epidemiology of intraocular melanoma. Recent results. Cancer Res 1986;102:159-65.
55. Lock-Andersen J, Wulf HC, Knudstorp ND. Interdependence of eye and hair colour, skin type and skin pigmentation in a Caucasian population. Acta Derm Venereal 1998;78:214-19.
56. Holly EA, Aston DA, Char DH, et al. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990;50:5773-7.
57. Schwartz SM, Weiss NS. Place of birth and incidence of ocular melanoma in the United States. Int J Cancer 1988;41:174-7 (published erratum appears in Int J Cancer 1988;41:779).
58. Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol 1990;108:1274-80.
59. English DR, Armstrong BK, Kricker A, et al. Sunlight and cancer. Cancer Causes Control 1997;8:271-83.
60. Egan KM, Gragoudas ES, Seddon JM, et al. Smoking and the risk of early metastases from uveal melanoma. Ophthalmology 1992;99:537-41.
61. Albert DM. The association of viruses with uveal melanoma. Trans Am Ophthalmol Soc 1979;77:367-421.
62. Albert DM. The role of viruses in the development of ocular tumors. Ophthalmology 1980;87:12-25.
63. Albert DM, Puliafito CA, Fulton AB, et al. Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers. Am J Ophthalmol 1980;89:323-37.
64. Schoenberg BS, Christine BW. Malignant melanoma associated with breast cancer. South Med J 1980;73:1493-7.
65. Osterlind A, Olsen JH, Lynge E, et al. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:361-88.
66. Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:161-89.
67. Bataille V, Pinney E, Hungerford JL, et al. Five cases of coexistent primary ocular and cutaneous melanoma [see comments]. Arch Dermatol 1993;129:8-201.
68. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995;61:773-9.
69. Turner BJ, Siatkowski RM, Augsburger JJ, et al. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol 1989;107:601-8
70. Beral V, Evans S, Shaw H, et al. Malignant melanoma and exposure to fluorescent lighting at work. Lancet 1982;2:290-3.
71. Dolin PJ, Foss AJ, Hungerford JL. Uveal melanoma: is solar ultraviolet radiation a risk factor? Ophthalmic Epidemiol 1994;1:27-30.
72. Dolin PJ, Johnson GJ. Solar ultraviolet radiation and ocular disease: a review of the epidemiological and experimental evidence. Ophthalmic Epidemiol 1994;1:155-64.
73. Schwartz LH, Ferrand R, Boelle PY, et al. Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution. Radiat Res 1997;147:451-6.
74. Rosen ES. Filtration of non-ionizing radiation by the ocular media. In: Cronley-Dixon J, Rosen ES, Marshall J, eds. Hazards of light: myths and realities on the eye and skin. Oxford: Pergamon Press, 1986:145.
75. Mukai S, Dryja TP. Loss of alleles at polymorphic loci on chromosome 2 in uveal melanoma. Cancer Genet Cytogenet 1986;22:45-53.
76. Martinetti M, Tafi A, De Paoli F, et al. Immunogenetic heterogeneity of uveal melanoma. Cancer Detect Prev 1988;12:145-8.
77. Jager MJ, Volker-Dieben HJ, de Wolff-Rouendaal D, et al. Possible relation between HLA and ABO type and prognosis of uveal melanoma. Doc Ophthalmol 1992;82:43-7.
78. Conlon MR, Albert DM. Uveal melanoma. Int Ophthalmol Clin 1993;33:67-76.
79. Jay M, McCartney AC. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol 1993;37:457-62.
80. Gordon KB, Thompson CT, Char DH, et al. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res 1994;54:4764-8.
81. Neugut AI, Kizelnik-Freilich S, Ackerman C. Black-white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health 1994;84:1828-9.
82. Prescher G, Bornfeld N, Becher R. Two subclones in a case of uveal melanoma. Relevance of monosomy 3 and multiplication of chromosome 8q. Cancer Genet Cytogenet 1994;77:144-6.
83. Speicher MR, Prescher G, du Manoir S, et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 1994;54:3817-23.
84. Singh AD, Wang MX, Donoso LA, et al. Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental? Arch Ophthalmol 1996;114:1101-4.
85. Singh AD, Shields CL, De Potter P, et al. Familial uveal melanoma. Clinical observations on 56 patients [see comments]. Arch Ophthalmol 1996;114:392-9.
86. Singh AD, Shields CL, Shields JA, et al. Bilateral primary uveal melanoma. Bad luck or bad genes? Ophthalmology 1996;103:256-62.
87. Miller B, Abrahams C, Cole GC, et al. Ocular malignant melanoma in South African blacks. Br J Ophthalmol 1981;65:720-2.
88. Albert DM, Shadduck JA, Lin HS. Animal models for the study of uveal melanomas. Int Ophthalmol Clin 1980;101:177-85.
89. Vagero D, Swerdlow AJ, Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990;47:317-24.
90. Ajani UA, Seddon JM, Hsieh CC, et al. Occupation and risk of uveal melanoma. An exploratory study. Cancer 1992;70:2891-900.
91. Hsieh CC, Walker AM, Hoar SK. Grouping occupations according to carcinogenic potential: occupation clusters from an exposure linkage system. Am J Epidemiol 1983;117:575-89.